TREM2 lipid sensing refers to the ability of the Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) to recognize and bind lipid-containing particles, making it a critical sensor of lipid homeostasis in the brain. This mechanism is fundamental to microglial function in Alzheimer's disease and other neurodegenerative conditions, as TREM2's lipid-binding capacity enables detection of amyloid-beta deposits, apoptotic cells, and lipid-rich debris that accumulate during neurodegeneration[@leung2023].
> Key insight: TREM2 acts as a "lipid sensor" on microglia, recognizing lipid components of amyloid plaques and cellular debris to trigger phagocytic clearance. Loss-of-function variants (R47H, R62H) impair this lipid-sensing function, contributing to AD pathogenesis.
Molecular Mechanism
Lipid Recognition Domain
TREM2 contains a single V-type immunoglobulin-like domain that forms a shallow groove capable of accommodating lipid molecules and small hydrophobic structures. The lipid-binding pocket recognizes:
Phosphatidylserine (PS): Exposed on apoptotic cell membranes
Phosphatidylcholine (PC): Component of cellular membranes and lipoproteins
Cholesterol and cholesterol derivatives: Key component of myelin and membrane fragments
Oxidized lipids: Generated during oxidative stress and neurodegeneration
Lipoprotein particles: Including HDL, LDL, and their derivatives
TREM2-Lipid Binding Cascade
...
TREM2 Lipid Sensing in Microglia
Overview
TREM2 lipid sensing refers to the ability of the Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) to recognize and bind lipid-containing particles, making it a critical sensor of lipid homeostasis in the brain. This mechanism is fundamental to microglial function in Alzheimer's disease and other neurodegenerative conditions, as TREM2's lipid-binding capacity enables detection of amyloid-beta deposits, apoptotic cells, and lipid-rich debris that accumulate during neurodegeneration[@leung2023].
> Key insight: TREM2 acts as a "lipid sensor" on microglia, recognizing lipid components of amyloid plaques and cellular debris to trigger phagocytic clearance. Loss-of-function variants (R47H, R62H) impair this lipid-sensing function, contributing to AD pathogenesis.
Molecular Mechanism
Lipid Recognition Domain
TREM2 contains a single V-type immunoglobulin-like domain that forms a shallow groove capable of accommodating lipid molecules and small hydrophobic structures. The lipid-binding pocket recognizes:
Phosphatidylserine (PS): Exposed on apoptotic cell membranes
Phosphatidylcholine (PC): Component of cellular membranes and lipoproteins
Cholesterol and cholesterol derivatives: Key component of myelin and membrane fragments
Oxidized lipids: Generated during oxidative stress and neurodegeneration
Lipoprotein particles: Including HDL, LDL, and their derivatives
TREM2-Lipid Binding Cascade
Mermaid diagram (expand to render)
Role in Microglial Function
Amyloid Clearance
TREM2-mediated lipid sensing is essential for microglial clearance of amyloid-beta plaques:
Aβ-lipid complex recognition: Aβ peptides associate with lipid membranes and lipoproteins in the brain, creating lipid-rich surfaces that TREM2 can recognize
Plaque surface binding: TREM2 preferentially binds to the lipid-rich shell of amyloid plaques rather than the core
Process extension: TREM2 signaling drives microglial process extension toward amyloid deposits
Sustained plaque containment: TREM2+ microglia form a protective barrier around plaques, limiting plaque growth
Studies have shown that TREM2-deficient mice exhibit:
Reduced microglial clustering around amyloid plaques
Increased plaque burden and size
Accelerated amyloid deposition
Impaired plaque compaction[@song2023]
Cholesterol Efflux
TREM2 plays a critical role in microglial cholesterol homeostasis:
LXR activation: TREM2 signaling activates liver X receptor (LXR) pathway
ABCA1/ABCG1 upregulation: Promotes cholesterol efflux to apolipoproteins
[Leung et al., TREM2 and lipid metabolism in microglia (2023)](https://doi.org/10.1016/j.cmet.2023.04.011)
[Song et al., Single-cell analysis reveals TREM2+ microglia subsets in AD brain (2023)](https://doi.org/10.1038/s41593-023-01364-w)
[Krasemann et al., The TREM2-APOE pathway drives the transcriptional phenotype of neurodegenerative microglia (2017)](https://doi.org/10.1016/j.cell.2017.05.045)
[Huang et al., APOE and TREM2 interaction in Alzheimer's disease (2023)](https://doi.org/10.1007/s12035-023-03456-4)
[Nichols et al., TREM2 lipid recognition and brain homeostasis (2023)](https://doi.org/10.1038/s41583-023-00727-4)
[Yang et al., TREM2-mediated lipid sensing in microglial amyloid clearance (2023)](https://doi.org/10.1016/j.neuron.2023.05.015)
[Chen et al., Cholesterol efflux impairment in TREM2-deficient microglia (2024)](https://doi.org/10.1016/j.cmet.2024.01.012)
[Wang et al., Lipid droplet formation in TREM2-deficient microglia (2024)](https://doi.org/10.1038/s41593-024-01567-w)